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Abstract
DinB (DNA Pol IV) is a translesion (TLS) DNA polymerase, which inserts a nucleotide opposite an otherwise replication-
stalling N
2-dG lesion in vitro, and confers resistance to nitrofurazone (NFZ), a compound that forms these lesions in vivo.
DinB is also known to be part of the cellular response to alkylation DNA damage. Yet it is not known if DinB active site
residues, in addition to aminoacids involved in DNA synthesis, are critical in alkylation lesion bypass. It is also unclear which
active site aminoacids, if any, might modulate DinB’s bypass fidelity of distinct lesions. Here we report that along with the
classical catalytic residues, an active site ‘‘aromatic triad’’, namely residues F12, F13, and Y79, is critical for cell survival in the
presence of the alkylating agent methyl methanesulfonate (MMS). Strains expressing dinB alleles with single point
mutations in the aromatic triad survive poorly in MMS. Remarkably, these strains show fewer MMS- than NFZ-induced
mutants, suggesting that the aromatic triad, in addition to its role in TLS, modulates DinB’s accuracy in bypassing distinct
lesions. The high bypass fidelity of prevalent alkylation lesions is evident even when the DinB active site performs error-
prone NFZ-induced lesion bypass. The analyses carried out with the active site aromatic triad suggest that the DinB active
site residues are poised to proficiently bypass distinctive DNA lesions, yet they are also malleable so that the accuracy of the
bypass is lesion-dependent.
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Introduction
Replicative DNA polymerases are multi-protein complexes
responsible for synthesizing a high fidelity copy of a cell’s genome.
Persistent lesions on the template DNA, which DNA repair
pathways have failed to recognize, result in stalling of DNA
replication, a potentially lethal event [1]. To avoid lethality,
specialized DNA polymerases insert deoxynucleotides (dNTPs)
opposite replication-blocking DNA lesions in a process known as
translesion synthesis (TLS). This is largely a low fidelity process
usually resulting in elevated mutagenesis [1,2]. In Escherichia coli
there are three TLS polymerases that are regulated by the SOS
gene network, one of the cellular responses to DNA damage and
environmental stress [1,3]. The polB gene encodes the B family
DNA Pol II, while the dinB gene and the umuDC operon encode
the two Y family DNA polymerases, DNA Pol IV and DNA Pol V
respectively [1,4,5,6,7]. DinB is of particular interest because of its
evolutionary conservation [1,6,8] and its high basal intracellular
concentration (,250 nM) [1,9,10]. Indeed, this is approximately
17 fold higher [10] than that of DNA Pol III complex (the
replicative DNA polymerase, 15 nM; [9]) and is similar to that of
the processivity clamp (b-clamp, 250 nM; [11,12]), an essential
replication factor known to both recruit all DNA polymerases to
the replication fork and manage their activity in the cell [13,14].
E.coli cells lacking the dinB gene (DdinB) are sensitive to
nitrofurazone (NFZ) and 4-nitroquinoline-1-oxide (4-NQO)
[15,16], reagents that create persistent DNA lesions on the N
2
group of deoxyguanosine (N
2-dG) [17,18]. Recent evidence
suggests that DinB and its homologues can also perform TLS of
lesions that are the product of alkylation of DNA bases [19,20,21].
Alkylating agents are both a byproduct of the cell’s metabolism
and also come from diverse exogenous sources generating DNA
damage in prokaryotic and eukaryotic cells [1,22,23,24,25]. In
addition, alkylating agents are used as anti-cancer chemothera-
peutic agents, [1,26,27], underscoring the significance of under-
standing the cellular mechanisms of alkylation lesion tolerance.
It is known that base excision repair pathways are the primary
cellular response to alkylation damage [1,28,29,30,31,32], though
Y family DNA polymerases are also part of this response
[1,19,20,21]. These polymerases likely bypass 3-methyladenine
(3-meA; [1,19,20,21,33,34]), a prevalent alkylation lesion that
persists on the DNA and brings about replication fork stalling and
cell death [20,21,35,36]. Indeed, E. coli strains lacking the dinB
gene (DdinB) are sensitive to several alkylating agents, such as
methyl methanesulfonate (MMS; [19]). Similar sensitivity is found
in eukaryotic cells deficient in TLS polymerases [20,21]. Thus, the
evidence so far indicates that if DNA repair pathways do not
effectively recognize 3-meA, Y family DNA polymerases are
PLoS ONE | www.plosone.org 1 May 2011 | Volume 6 | Issue 5 | e19944critical in the cell’s response to alkylation damage [19,20,21].
Unfortunately, 3-meA has a very short in vitro half-life [21,37],
making difficult to directly investigate the bypass mechanisms of
this alkylation lesion.
Most of our knowledge in regard to the active site of DinB has
been acquired through studies with reagents that generate N
2-dG
lesions [15,16]. However, it is not known which aminoacids in the
DinB active site are important for the bypass of alkylation lesions,
e.g. most likely 3-meA. It is also unclear whether the same active
site residues are involved in the bypass or its fidelity of both
alkylation and N
2-dG lesions. Structural modeling predicts that Pol
k (the mammalian DinB homologue) could accommodate either
the N
2-dG or 3-meA minor groove adducts in its active site in a
conformation that would allow both insertion and extension from
either adduct [20].
We studied a triad of aromatic residues (Fig. 1) that is conserved
in Y family DNA polymerases including Pol g and Pol k [38,39]
and used as a control the strictly catalytic aspartic acid 103 (D103).
This is known to be critical for DNA synthesis and thus unable to
complement a DdinB strain [16,40,41]. Here, we describe the
analysis of the aromatic triad residues of DinB in response to DNA
damage generated by treatment with MMS or NFZ, reagents that
create respectively alkylation or N
2-dG lesions in vivo. This report
describes the effect of changing the aromatic triad residues to those
of different polarity or size on both survival and DNA damage-
induced mutagenesis. This type of analysis has permitted us to
learn about the intricacies of in vivo DinB lesion bypass activities.
We infer that the classical catalytic and the highly conserved DinB
active site ‘‘aromatic triad’’ are necessary for TLS of alkylation
lesions. Remarkably, the aromatic triad also serves the function of
governing in vivo TLS fidelity, which seems to be lesion-dependent.
Results
DinB active site residues are important for survival in
MMS
The two catalytic activities of DinB, phosphodiester bond
formation (i.e. DNA synthesis) and lesion bypass are separable
[16]. Each activity can be tested in vivo by measuring survival of
cells lacking the chromosomal copy of the dinB gene (DdinB) after
treatment with a DNA damaging agent. Because some alkylation
lesions are chemically unstable (e.g. 3-meA), we took advantage of
this genetic approach to determine whether DdinB cells expressing
plasmid-borne dinB alleles with mutations in the aromatic triad
could survive MMS treatment.
Low copy number plasmids expressing different dinB alleles
from the native SOS inducible promoter were introduced into
DdinB by transformation (Table S1). Cells were then assayed for
survival at various concentrations of MMS. As expected, the
plasmid carrying native dinB
+ rescues DdinB treated with MMS
(Figs. S1 and 2), while the strain expressing the catalytically
inactive dinB(D103N) variant [41] is highly sensitive to MMS
treatment (Figs. S1 and 2). Unexpectedly, DdinB cells expressing
dinB(F13V) did not show the prototypical highly NFZ sensitive
phenotype [16] upon treatment with MMS (Figs. S1 and 2).
We were intrigued by the enhanced cellular sensitivity to MMS
(DdinB with the dinB(D103N), gray bars; Fig. 2) or NFZ (DdinB with
either the dinB(D103N) or dinB(F13V), white bars; Fig. 2)
compared to DdinB. The simplest explanation is that the
phenotype is due to high DinB intracellular concentrations,
despite being expressed under the SOS-regulated native promoter
and from low copy number plasmids. Increased intracellular
concentrations of DinB variants may somehow have a more
deleterious effect on survival than lack of DinB. Thus, the
dinB(D103N) and dinB(F13V) alleles (Table S1) were crossed onto
the chromosome replacing dinB
+, as indicated in Materials and
Methods. Consistent with the hypothesis, we find that cells with a
chromosomal copy of dinB(D103N) are no longer highly sensitive
to MMS (compare ,100 fold more killing than DdinB in Fig. 2
with the same lethality as DdinB in Fig. 3) or NFZ at any of the
concentrations tested, and survive treatment as DdinB cells (Fig. 3).
Conversely, cells with dinB(F13V) in the chromosome remain more
sensitive to NFZ than DdinB, though the extent of sensitivity is less
dramatic in the chromosome (,10 fold, white bars; Fig. 3). These
data demonstrate that the observed exacerbated sensitivity
phenotypes of DdinB strains with plasmid-borne TLS deficient
dinB alleles are not solely due to elevated intracellular concentra-
Figure 1. Homologous E. coli DinB and human Pol k aromatic
triads appear similarly positioned in the active site. The near
identical conformation of the aromatic triads of (A) DinB (Pol IV) (F12,
F13 and Y79) and (B) Pol k (F111, Y112, and Y174) suggests these
residues could be required for TLS activity of Pol k. The DinB structure is
from an in silico model generated in collaboration with A. Abyzov and V.
Ilyin [40]. Image generated using PyMOL (DeLano, W.L. The PyMOL
Molecular Graphics System (2002) DeLano Scientific, San Carlos, CA,
USA.). Pol k structure was rendered using the pdb 3IN5 with PyMOL.
doi:10.1371/journal.pone.0019944.g001
Figure 2. DdinB is rescued from MMS and NFZ lethality only by
dinB
+. (A) Neither plasmid-borne DinB(D103N) nor DinB(F13V) rescue
DdinB cells treated with MMS (7.5 mM) or NFZ (0.008 mM). Enhanced
sensitivity to MMS is observed in DdinB with DinB(D103N) (gray bars).
DdinB strains with either DinB(F13V) or DinB(D103N) variants exhibit an
enhanced cellular sensitivity to NFZ compared to DdinB (pVector, white
bars) as previously reported [16]. Error bars represent the standard
deviation of the mean from at least 3 independent experiments.
doi:10.1371/journal.pone.0019944.g002
Pol IV Active Site Aromatic Triad and Mutagenesis
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phenomenon is/are not fully understood.
The aromatic triad is required for in vivo DinB TLS
In an effort to gain insights into the TLS activity of DinB in
alkylation lesion bypass, we looked for conserved residues in the
DinB active site that could be as important as F13 in DinB N
2-dG
TLS. This analysis, carried out with a large number of DinB
sequences (.100) in both prokaryotic and eukaryotic organisms
(including the DinB human homologue Pol k), surprisingly shows
that phenylalanine 13 (F13) is only somewhat conserved (42%).
However, if the analysis also considers tyrosine, a structurally
similar residue, then F13/Y13 becomes 97% conserved. We
hypothesized that the aromatic ring of tyrosine or phenylalanine
fulfills an identical role in lesion bypass. We constructed a DinB
derivative with a tyrosine at position 13 instead of phenylalanine
(pdinB(F13Y)) in the same low copy number plasmid mentioned in
the above section, and introduced it by transformation into DdinB.
As predicted, the DdinB/pdinB(F13Y) strain has the same level
survival after MMS or NFZ treatment as cells with wild-type
DinB
+ (Fig. 4).
We have shown (Figs. S1, 2 and 3) that F13 is important for the
TLS of alkylation lesions, but strains expressing this allele survive
better in MMS than in NFZ regardless of the allele location (Figs. 2
and 3). F13 was also changed to alanine or serine. Unlike
dinB(F13V), both dinB(F13A) (data not shown) and dinB(F13S)
(Fig. 4) result in decreased survival of DdinB cells upon NFZ or
MMS treatment independent of whether the dinB alleles are
expressed from a plasmid (Fig. 4) or from the chromosome (Fig. 3).
It can be inferred from these data that the role of the F13 residue
in the DinB bypass of alkylation DNA lesions is likely different
from its role in N
2-dG bypass, but is nevertheless essential for the
bypass of MMS-derived lesions in vivo.
The two other aromatic residues that are also highly conserved
(.95% conservation among DinB sequences) and happen to be in
close proximity to F13 in the DinB tertiary structure are Y79 and
F12 (Fig. 1). The conservation is true even at the structural level
(Fig. 1, compare DinB and Pol k) suggesting that, unlike F13, both
the aromatic ring and the polarity of these residues might be
equally important for lesion bypass.
We changed each one of these residues, and assessed their
function by measuring survival of DdinB carrying the various dinB
alleles upon MMS or NFZ treatment. Y79 or F12 were changed to
the aromatic residue with the opposite polarity (phenylalanine or
tyrosine respectively) or to the non-aromatic residues alanine or
serine.
There is no measureable survival defect for the DdinB strain upon
MMS treatment when the conserved Y79 residue is replaced by
phenylalanine (Fig. 4). However, DdinB cells expressing dinB(Y79A)
show an enhanced sensitivity to MMS or NFZ compared to DdinB
(pVector; Fig. 4). A similar enhanced sensitivity, though not to the
samedegree,wasobserved inNFZ-treated cellswhenthedinB(Y79A)
allele is expressed from the chromosome (Fig. 3). In contrast, the
result of exchanging the tyrosine for a non-aromatic amino acid of
the same polarity, serine, leads to poor survival in MMS or NFZ
treatment, similar to that shown by the DdinB strain (Fig. 4).
DdinB expressing the plasmid-borne dinB(F12Y) allele, however,
show reduced survival in MMS or NFZ when compared to cells
carrying pdinB
+, but survive better than DdinB, suggesting that
TLS is lessened but not abolished in this variant (Fig. 4). This is
confirmed by changing F12 to alanine (Fig. 4), which results in
survival similar to that of cells lacking dinB. We also investigated
the effect of changing F12 to a non-aromatic residue of the
opposite polarity and found that the F12S mutation does abolish
TLS activity in vivo, similar to the F12A mutation (data not shown).
Taken together, the data demonstrate that the aromatic triad
consisting of F12, F13, and Y79 are all needed for survival in
MMS. The relevance of each residue in TLS varies depending on
the lesion and is independent of the location (plasmid or
chromosome) of the dinB TLS deficient allele. Importantly, the
absolute requirement of these residues for DinB lesion bypass, and
the evolutionary conservation of these aromatic residues, suggest
Figure 3. MMS or NFZ survival phenotypes of strains with
catalytic or TLS deficient dinB chromosomal alleles. Cells carrying
a single chromosomal copy of the catalytic deficient dinB(D103N), the
TLS deficient dinB(F13V), and other dinB alleles were assayed for survival
as indicated in material and methods with MMS (7.5 mM) or NFZ
(0.008 mM). Error bars represent the standard deviation of the mean
from at least 3 independent experiments.
doi:10.1371/journal.pone.0019944.g003
Figure 4. An aromatic triad in the DinB active site is required
for DdinB survival upon treatment with MMS or NFZ. DdinB
harboring the dinB alleles with mutations at position 12, 13, and 79
were treated with MMS (7.5 mM; gray bars) or NFZ (0.008 mM; white
bars). Treatments were carried out as described in materials and
methods. Error bars represent the standard deviation of the mean from
at least 3 independent experiments. Only top error bars are shown for
clarity.
doi:10.1371/journal.pone.0019944.g004
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such as human Pol k (Fig. 1).
Survival effects of various dinB alleles expressed in DdinB
depend on both the lesion and the DinB processivity
clamp-binding motif
We asked whether the survival phenotypes of DdinB expressing
various DinB variants were independent of the DNA damaging
agent used to treat cells. We took advantage of the enhanced
sensitivity phenotype observed in DdinB strains such as those
carrying plasmid-borne dinB(D103N),dinB(F13S),anddinB(Y79A)(to
MMS or NFZ), or dinB(F13V) (to NFZ). We have already shown
(Fig. 3) that the increased sensitivity of the DdinB/pdinB(D103N)
strain to MMS or NFZ compared to DdinB, is likely due to elevated
intracellular concentrations. Nonetheless, when compared to DdinB,
expression of the dinB(F13S), dinB(Y79A),o rdinB(F13V) alleles
results in enhanced sensitivity to DinB cognate lesions regardless of
whethertheyareexpressedfromaplasmidorfromthechromosome
(see Figs. 2, 3, and 4). Therefore, if survival upon MMS or NFZ
treatment is TLS independent, dinB(F13V), and especially
dinB(D103N) should render DdinB strains sensitive to any DNA
damaging agent regardless of the lesion it might bring about. UV
damage was chosen to test this model because DinB is unable to
bypass the thymine-thymine dimer lesions generated in the major
grove of the DNA upon treatment [42]. 37 J/m
2 of UV light, a
dosage at which DdinB or dinB
+ strains are equally killed was used to
treat DdinB strains with these dinB alleles. We find that DdinB cells
bearing either the dinB catalytic or TLS deficient alleles survive as
well as DdinB or dinB
+ strains upon UV treatment. In contrast, at
comparable levels of MMS or NFZ treatment, DdinB strains
expressing DinB(D103N) or DinB(F13V), show enhanced sensitivity
to MMS or NFZ (Fig. 5). Thus, only DinB cognate lesions result in
poor survival of DdinB cells expressing these dinB alleles, suggesting
that survival in MMS or NFZ treatment is linked to TLS.
We next investigated whether the DinB variant-mediated
enhanced sensitivity in MMS or NFZ requires the carboxy
terminal residues known to interact with the processivity factor b-
clamp [43]. Thus, derivatives of DinB(F13V), DinB(D103N), and
DinB
+, as a control, lacking the DinB b-clamp binding motif
(
347LVLGL
351; [43,44]) were constructed in the same low copy
number plasmids (Table S1). If DdinB strains expressing DinB
variants lacking the b-clamp binding motif are as sensitive to either
MMS or NFZ as DdinB, then it could be inferred that the observed
enhanced sensitivity is mediated through interactions with the b-
clamp, and is consistent with the idea that these DinB variants are
localized at the replication fork. We found that DdinB with
pdinB
+Db are more sensitive to MMS or NFZ compared to pdinB
+
(Fig. 6). In contrast, DdinB cells expressing DinB(D103N)Db on
MMS or NFZ (Fig. 6) and those expressing DinB(F13V)Db on
NFZ (Fig. 6B) are more resistant to these DNA damaging agents.
These data suggest that the enhanced sensitivity observed with
these dinB alleles is dependent on the b-clamp binding motif. This
is perhaps the result of the interaction of DinB with the b-clamp,
which is likely to be occurring at the replication fork.
From these independent sets of data we can deduce that the in
vivo phenotypes observed in cells expressing dinB catalytic or other
Figure 5. dinB deficient alleles affect DdinB survival only upon
treatment with reagents that generate DinB cognate lesions.
DdinB strains carrying the plasmid-borne variants of DinB were
compared at levels of UV (37 J/m
2) at which DdinB and dinB
+ are
equally killed (black bars). Significant variations in survival were only
observed upon comparable levels of MMS (7.5 mM; gray bars) or NFZ
(0.008 mM; white bars) treatments. Error bars represent the standard
deviation of the mean from at least 3 independent experiments. Only
top error bars are shown for clarity.
doi:10.1371/journal.pone.0019944.g005
Figure 6. DdinB with variants lacking the residues comprising
the b-clamp binding motif are no longer highly sensitive to
MMS or NFZ. (A) A representative LB medium plate containing MMS
(7.5 mM) with 10 fold serial dilutions of DdinB cells bearing the plasmid-
borne dinB alleles is shown. (B) Same as (A) except cells were deposited
on LB medium plates with NFZ (0.008 mM).
doi:10.1371/journal.pone.0019944.g006
Pol IV Active Site Aromatic Triad and Mutagenesis
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bypass.
DNA damage-induced mutation frequency as a measure
of accurate TLS activity
In this report we present a DNA damage-induced mutagenesis
screen with a substantial mutational target size [45,46]. Cells are
treated with either MMS or NFZ at concentrations where DdinB
cells are equally killed, i.e. 7.5 mM MMS and 0.008 mM NFZ.
Bacterial colonies that survive the treatment are then screened for
loss of growth in minimal medium. A very conservative estimation
of the target size is between 35 and 100 Kb, since any mutation that
results inthe inabilitytogrowinminimalmediumwillbescoredasa
mutant. These include genes involved in amino acid, vitamin, or
nucleotide biosynthesis. There is no selection in the detection of the
mutant population that arises as the result of DNA damage and
mutant colonies unable to grow in minimal medium are clonal.
We find that there is virtually no DNA damage-induced
mutagenesis in DdinB expressing dinB
+ (Fig. 7). Importantly,
although DinB is arguably at higher intracellular concentration
than when expressed from a single chromosomal copy, it does not
increase DNA damage-induced mutant frequency in this assay
simply by being at a higher intracellular concentration. We also
found low frequencies of mutants in DdinB and in DdinB expressing
the catalytically inactive dinB(D103N) (Fig. 7), both of which are
presumed to be the consequence of an activity independent from
DinB.
Cells expressing dinB with mutations in the aromatic triad
residues F13, Y79, and F12 display a frequency of MMS-induced
mutants similar to DdinB or to the DdinB/pdinB(D103N) strain
(Fig. 7). We find that DdinB cells expressing the DinB(F13V)
variant have a modest increase in both MMS and NFZ-induced
mutant frequency when compared to either DdinB or to those
expressing DinB(D103N) (Fig. 7). Unexpectedly, there is a
Figure 7. DNA damage-induced mutants. (A) DdinB with plasmid-borne DinB variants were treated with MMS (7.5 mM), NFZ (0.008 mM), or UV
light (37 J/m
2) and screened for mutants unable to grow on glucose minimal medium. Only DdinB strains carrying plasmid-borne dinB
+, dinB(D103N),
dinB(F13V), dinB(F13S),o rdinB(Y79A) alleles were assessed for UV-induced mutants. NFZ-induced mutants were also ascertained in the dinB(Y79A)
strain in which the DinB variant is expressed from the chromosome (bold font). Mutants were equally distributed when independent cultures were
analyzed. All samples have a standard error #5% of the average of mutants obtained per individual culture. (B) The fold difference shown in mutants
is relative to DdinB.
doi:10.1371/journal.pone.0019944.g007
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expressing pdinB(F13S),p dinB(Y79A),o rp dinB(Y79S) (Fig. 7).
Notably, this increase is also observed in the dinB(Y79A)
chromosomal strain (Fig. 7; bold font).
We also assessed the number of UV-induced mutants to validate
the level of mutagenesis that is DinB-independent. We expected
that UV-induced mutant frequencies would be similar to DdinB or
DdinB strains expressing the catalytically inactive derivative
DinB(D103N) after NFZ or MMS treatment. This is what was
observed (Fig. 7) in the cases where it was determined.
Intriguingly, we observed an increase in UV-induced mutants in
strains expressing pDinB
+ but not pDinB(D103N) (compare
columns NFZ or MMS with UV for pDinB
+ in Fig. 7A). This
has been previously reported for DinB
+, in an independent
experiment in which selection for UV-induced Arg
+ mutants was
carried out [40]. Thus, there might be a role for DinB, or more
likely DinB with its interacting partners [40], in regulating this
mutagenesis.
MMS induces the SOS-gene network more strongly than
NFZ
The difference between NFZ- and MMS-induced mutant
frequencies might be due to a fundamental distinction between
the mechanisms regulating DinB alkylation or N
2-dG lesion
bypass. Perhaps there are other SOS induced proteins that might
explain the elevated mutant frequency observed exclusively upon
NFZ treatment. To measure the relative induction of the SOS-
gene network in cells treated with MMS or NFZ, a green
fluorescent protein (GFP; [47]) reporter plasmid was used. In this
assay GFP is expressed under the regulation of the sulA gene
promoter, an SOS-network gene [48], and GFP fluorescence is
thus an indicator of SOS induction. This plasmid was introduced
into both dinB
+ and DdinB strains by transformation. In this
experiment ciprofloxacin [49] instead of UV irradiation was
chosen as the SOS inducer to directly evaluate GFP fluorescence
in a comparable time frame.
We find that expression of GFP upon treatment with a DNA
damaging agent is dinB independent (Figs. 8 and S2). Strikingly, we
find that GFP fluorescence is greater in cells treated with MMS
than in those treated with NFZ (Figs. 8 and S2). Moreover, no
fluorescence was detected at NFZ concentrations lower than
0.06 mM, the concentration depicted in Fig. 8. Yet the NFZ
concentration used to treat cells throughout this report is 7.5 times
lower i.e. 0.008 mM, an NFZ concentration insufficient to induce
the SOS response at levels similar to those measured in MMS
treatment. Thus, it can be inferred that the large number of NFZ-
induced mutants is specific to the N
2-dG lesions and not due to
overexpression of any other SOS-induced activity.
Taken together, this evidence indicates that the aromatic triad
residues play different and nuanced roles in the TLS of MMS- and
NFZ-induced lesions. The analyses carried out suggest that the
active site is pliable and that the aromatic triad is essential for both
bypass and accuracy.
Discussion
Much has been learned about the Y family translesion (TLS)
DNA polymerase DNA Pol IV (DinB) in E. coli [1,6,50]. This
DNA polymerase inserts a nucleotide opposite specific DNA
lesions (i.e. bypass or translesion synthesis activity) with relatively
high accuracy compared to other Y DNA polymerases [15,16].
Though under some conditions DinB has been shown to cause 21
frameshift mutations on misaligned templates [40,51,52], this
appears to be regulated by protein-protein interactions [40,51].
However, knowledge is lacking in regard to the role played by
DinB’s active site residues, in alkylation lesion bypass. Moreover, it
is not known whether residues in the active site play a role in the
accuracy of bypass of distinct DNA lesions. To fill this knowledge
gap, we have undertaken structure/function analyses of the DinB
active site and have gained insights into the active site residues that
govern bypass and fidelity of different lesions. In the experiments
reported here we use MMS and NFZ, reagents known to cause
DNA lesions that kill cells without DinB [16,19]. Specifically, we
studied an aromatic residue triad F12, F13, and Y79 in the DinB
active site (Fig. 1) by changing these conserved residues to ones of
different size and polarity. Notably, this is the first report in which
a number of these DinB variants have been studied when
expressed from the chromosome.
The F13 residue is critical for both in vivo and in vitro DinB
mediated bypass of N
2-dG lesions [16]. Agreeing with previously
published reports [16], expression of the DinB(F13V) variant in
DdinB cells from a low copy number plasmid causes enhanced
NFZ sensitivity (Fig. 2). This phenotypic signature is remarkably
maintained when this dinB allele is expressed from the chromo-
some (Fig. 3). Notably, there is no enhanced sensitivity to MMS
(Figs. 2 and 3), suggesting that the DinB active site adjusts to
lesions. Thus, the relevance of different catalytic residues for
bypass activity is likely to be lesion dependent.
We investigated whether changing the aromatic triad residues to
different aromatic residues compromised the bypass activity of E.
coli DinB. Our results show that the polarity of the aromatic
residue is important for the F12 residue but not for the others
(Fig. 4). It can be inferred that either a phenylalanine or a tyrosine
at the F13 or Y79 positions allows for the insertion of a nucleotide
opposite an N
2-dG or an alkylation lesion, resulting in no change
in the activity of the DNA polymerase. A comparable result has
been found in B-family DNA polymerases [53,54] when a similarly
positioned residue was changed from a tyrosine to a phenylala-
Figure 8. Relative induction of the SOS gene network in cells
treated with MMS or NFZ. dinB
+, DdinB, and DrecA strains carrying a
plasmid that expresses GFP from an SOS inducible promoter (sulAp-
GFP) were treated with MMS (7.5 mM), NFZ (0.06 mM shown), or the
strong SOS inducer ciprofloxacin (Cip) (0.1 mg/mL) [49]. dinB
+ and DdinB
strains display a significant 50% increase, compared to the control
DrecA strain, in the ratio of Fluorescence/OD600 after 2 hours of NFZ
treatment and after 1.5 hours of both MMS and ciprofloxacin
treatments, 5 hours is shown. For 20 hour kinetic see Fig S2. No
increased fluorescence is detected in NFZ concentrations below
0.06 mM (data not shown) when compared to untreated dinB
+ and
DdinB cells, or the DrecA negative control during the time frame the
experiment was carried out (see Fig S2 for 20 hour kinetic). Error bars
represent the standard deviation of the mean from at least 4 replicates.
doi:10.1371/journal.pone.0019944.g008
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that the DinB(F12Y) mutation reduces hydrophobic packing,
which in turn leads to reduced TLS; however, in the Y79F
mutation, the phenylalanine is able to stabilize the F13 residue
allowing for efficient TLS. A recent study demonstrated that the
active site residue Y112 (F13 in DinB) of the human DinB
counterpart, Pol k, is required not only for effective bypass of
certain lesions and exclusion of rNTPs from DNA synthesis, but
also for mismatch-primer extension [56]. It is plausible that
mutations in either F111 (F12) or Y174 (Y79) could abolish the
ability of Pol k to carry out any of these functions.
We further analyzed these three key aromatic residues by
assaying survival of DdinB strains bearing plasmid-borne DinB
variants in which each of the aromatic triad residues were mutated
to amino acids without aromatic rings. None of these variants
rescued DdinB strains upon MMS or NFZ treatment, a phenotype
that was maintained independently of the allele location (Figs. 3
and 4), suggesting that all three aromatic residues are essential for
bypass of both alkylation lesions and N
2-dG minor groove adducts.
It was plausible that poor survival in NFZ or MMS by DdinB
cells expressing the various dinB deficient alleles might be due to
increased intracellular DinB concentrations [57] and not neces-
sarily to TLS. If the variants were causing lethality due to, for
example, unregulated access to stalled replication forks; it should
be observed independent of both the treatment and the dinB
deficient allele tested. However, this is not the case (Fig. 5).
Provocatively, the poor survival phenotype is only observed when
cells are treated with either NFZ or MMS, but not with UV
(Fig. 5). We (Fig. 2), and others [16,19] have shown that DinB is
necessary for survival in alkylation or N
2-dG DNA damage,
demonstrating that MMS- and NFZ-induced lesions are cognate
DinB lesions, i.e. DinB activity is critical for survival. The same is
true for other DinB-like polymerases [20,21]. Differences in
survival are only observed when specific cognate lesions are
present on the DNA, suggesting that lesions might actively recruit
DinB polymerases to the replication fork, possibly increasing the
local polymerase concentration. The localized concentration of
DinB would then permit efficient exchange with the replicative
polymerase, probably via the b-clamp [58]. This suggests that
lesion specificity might play an important role in the TLS activity
of DinB. This concept of lesion-induced recruitment of Y family
DNA polymerases is similar to that occurring during somatic
hypermutation ([59] and references therein).
Importantly, the SOS gene network is robustly induced with
MMS but not so with NFZ. Indeed, at least a 7.5 fold higher NFZ
concentration than the one used here to routinely treat cells with
was required to detect any SOS induction (Fig. 8). Interestingly,
nitrofurantoin, another reagent within the class of activated
nitrofurans [60] is also a poor inducer of the SOS response
[61,62,63]. Thus, intracellular concentrations of DinB and other
SOS-induced proteins would be higher in MMS than in NFZ
treated cells. These results suggest that it is DinB and not other
SOS induced proteins that are responsible for the observed loss in
survival of DdinB cells expressing dinB catalytic or TLS deficient
alleles (Figs. 2, 3, and 4). Moreover, the phenotypic signature of
some of these deficient alleles is maintained when crossed onto the
chromosome (Fig. 3) suggesting that it is not exclusively due to
high intracellular concentrations. Finally, the DinB protein
appears to be properly localized at or near the replication fork
since cells carrying the dinB(F13V)Db or dinB(D103N)Db alleles,
which lack the conserved motif that permits DinB-b clamp
interactions, are no longer highly sensitive to MMS or NFZ (Fig. 6).
From these data we can infer that DinB and its variants have to be
at or near the replication fork to effect either survival or lethality of
cells upon treatment with reagents producing DinB cognate
lesions.
The analysis we have carried out indicates the aromatic triad in
the active site of DinB is needed for cells to survive NFZ or MMS
treatment because mutations in the aromatic triad impair in vivo
TLS.
Additionally, we report here that the aromatic triad is important
for the accuracy of DinB bypass. The MMS- or UV-induced
mutant frequency is quite low for DdinB strains carrying any of the
plasmid-borne DinB variants. Conversely, an NFZ-induced
mutator phenotype is apparent in DdinB cells carrying the
DinB(Y79A), DinB(Y79S), or DinB(F13S) derivatives. A similar
result is obtained with strains in which DinB(Y79A) is expressed
from the chromosome (Fig. 7). There are two possibilities as to
why only NFZ induced mutagenesis is observed: (1) low fidelity on
undamaged DNA, as some of these variants are known to be
incapable of TLS in vitro [15,16], and/or (2) mutagenesis is the
product of the in vivo TLS activity of these DinB variants. It is
possible the in vitro and in vivo properties observed in DinB(Y79)
variants are due to the inability of the new residue at position 79 to
properly support F13 in carrying out high fidelity bypass.
Although the substitution of valine for phenylalanine at position
13 does render DinB TLS deficient, it is only when a smaller serine
is substituted for phenylalanine that the fidelity of the polymerase
is severely compromised. All of these changes in either the F13 or
Y79 do not affect the bypass fidelity in MMS, presumably because
the active site is flexible and adapts to the different lesions. Perhaps
the fidelity of alkylation lesion bypass is regulated differently from
the fidelity of NFZ-induced lesion bypass.
The observed NFZ-induced mutants are also likely DinB
dependent. If the mutants were occurring as a result of the action
of another polymerase, i.e. DNA Pol V, it would have been
evident in the UV-induced mutagenesis assay. UV treated cells
expressing DinB variants, display a number of DNA damage-
induced mutants that are, for the most part, equivalent to the level
of mutants found both in DdinB carrying the DinB(D103N)
variant, which is unable to synthesize DNA, and to cells without
DinB (Fig. 7). Furthermore, there is evidence that DNA Pol II is
not involved in the bypass of MMS- or NFZ-derived lesions in cells
that are proficient for base or nucleotide excision repair [19,64],
making it difficult to envision a simple model in which DNA Pol II
is responsible for the observed DNA damage-induced mutagenesis.
We carried out Illumina deep sequencing of the genome of several
independent MMS treated DdinB/pdinB(D103N) or pdinB(F13V)
strains that we identified as mutants based on their inability to
grow in minimal medium. Strikingly, MMS-induced mutants of
DdinB/pdinB(D103N) have only single base pair substitutions
(SNPs), including those in genes which could be responsible for the
lack of growth in minimal medium (data not shown). Notably,
both SNPs and 21 frameshifts (the mutational signature of
DinB(F13V) [40]) were detected in mutants derived from DdinB/
pdinB(F13V) strains. This evidence further suggests that DNA Pol
IV and its variants are responsible for effecting mutagenesis.
There is growing evidence for a role of DinB-like polymerases in
human cancers [65,66,67,68]. Thus, this triad of aromatic residues
in the DinB active site might be playing similar roles in DinB
homologues especially regarding fidelity. When compared to the in
silico model of DinB, the Pol k crystal structure shows that the
aromatic triad is identical in conformation (DinB F12, F13 and
Y79 are homologous to Pol k F111, Y112, and Y174; Fig. 1).
Notably, in the 1000 Genomes database [69] we find that there is
only one known polymorphism in the protein sequence of Pol k
that is homologous to E. coli DinB, (S423R), which is not an active
site residue. The lack of variations in the Pol k sequences,
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populations of E. coli select against polymorphisms in the DinB
catalytic domain [70]. The mutator phenotypes observed in cells
expressing DinB(F13S, Y79S, or Y79A) also indicate that
variations in homologous residues of Pol k could lead to a similar
reduction in TLS fidelity. The lack of polymorphisms in humans
might also be due to selection against such changes, perhaps the
result of embryonic lethality.
Thus, the analyses of the DinB active site and its aromatic triad
have provided insights into mechanisms that govern both TLS and
the fidelity of the bypass of different cognate lesions. In this regard,
we found a strikingly low level of DNA damage-induced mutants in
DdinB cells expressing wild type DinB from a low copy number
plasmid, despite it both being at a higher copy number than
chromosomal, and having a sizable mutational target. Furthermore,
we found few alkylation DNA damage-induced mutants, in
agreement with previous findings [19]. Finally, we found that the
aromatic triad plays a key role in the bypass fidelity of NFZ-induced
lesions. This supports the notion that N
2-dG lesions might indeed be
the preferred lesions recognized and bypassed by this DNA
polymerase. Although bacteria may encounter NFZ as an antibiotic
in the treatment of infections [71], we are still left with the question:
what is the endogenous source of N
2-dG lesions? We have no direct
answer yet to this question, however, since DinB-like DNA
polymerases are evolutionarily conserved, the source of their
preferred N
2-dG lesion substrate must be the result of an ordinary
metabolite. One exciting candidate is methylglyoxal, a byproduct of
glycolysis that can form N
2-(1-carboxyethyl)-29-deoxyguanosine (N
2-
CEdG) lesions that are bypassed by DinB and human Pol k [72].
We have shown here that the high fidelity of DinB is apparent
upon alkylation damage, an inescapable and pervasive form of
DNA damage, even when the DinB active site performs in vivo
error-prone NFZ-induced lesion bypass. In addition, we propose
that it is the nature of the lesion that localizes DinB to the
replication fork and facilitates protein-protein interactions to
prompt DNA polymerase exchange with the replicative DNA
polymerase when it has stalled.
Materials and Methods
Bacterial Strains and Plasmids
Bacterial strains and plasmids used in this report are listed in
Table S1. The P90C DdinB strain was generated by P1 transduction
using an allele from the KEIO collection [73] (a kind gift of the
Lewis lab at NEU). Plasmid-borne DinB mutants were constructed
using the GeneTailor Site-Directed Mutagenesis System (Invitro-
gen) and introduced into CaCl2 chemically competent cells by
transformation [74]. Mutagenic oligonucleotides are listed in Table
S1. Mutations were verified by DNA sequencing, carried out at the
Tufts University Core Facility in Boston, MA.
Survival Assays
Cultures were grown to saturation in either liquid LB or M9
minimal medium [74] with ampicillin (Amp, 200 mg/mL; Sigma).
Serial dilutions of saturated cultures were treated with varying
concentrations of methyl methanesulfonate (MMS, 5, 7.5, and
10 mM; Acros Organics), nitrofurazone (NFZ, 0.008 mM; Sigma),
or were irradiated in minimal medium at a UV (254 nm) intensity
of 37 J/m
2.
Construction of DinB Variants in the Chromosome
dinB(D103N), dinB(F13V), dinB(F13S), and dinB(Y79A) alleles
were introduced into the chromosome using the SOE-LRed
method [75].
Mutation Assays
Cells were evenly spread with glass beads onto LB medium with
7.5 mM MMS or 0.008 mM NFZ. These concentrations of MMS
and NFZ equally killed DdinB cells. UV irradiation (,37 J/m
2)
was carried out on M9 minimal medium supplemented with
casaminoacids [45]. Under these conditions, this level of
irradiation killed DdinB and dinB
+ cells to the same extent.
Surviving colonies were screened for loss of function on minimal
medium without amino acid supplementation [45], except for
proline [76], which is required by the parental strain. Three
independent experiments were carried out per DinB derivative
until a minimum of 1000 colonies were screened.
SOS Induction Assays
Cells bearing a plasmid expressing GFP from a sulA promoter
(pUA66-sulA, [47]) were grown to saturation in minimal medium
with Kanamycin (35 mg/mL; Sigma). These cultures were diluted 1
to 10 in the same growth medium with the appropriate
concentration of MMS (7.5 mM), NFZ (0.008–0.06 mM), or
ciprofloxacin (0.1 mg/mL, Cip; Sigma) in 96 well black plates with
clear flat bottom (Corning). The plates were incubated at 37uC with
intermittent shaking for 20 hours. GFP fluorescence (485/528 nm;
Excitation/Emission) and turbidity (600 nm) were measured every
5 minutes with in a BioTek Synergy HT-I plate reader.
Supporting Information
Figure S1 Kinetic of MMS lethality of DdinB strains
harboring either dinB
+ or catalytic/translesion deficient
dinB alleles. Only the plasmid-borne dinB
+ allele rescues DdinB
MMS sensitivity. Neither plasmid-borne DinB(D103N) nor
DinB(F13V) rescue DdinB cells treated with various concentrations
of MMS. Enhanced sensitivity is observed in DdinB strains
expressing DinB(D103N) when compared to DdinB. Error bars
represent the standard deviation of the mean from at least 3
independent experiments.
(TIF)
Figure S2 MMS is a more robust inducer of the SOS
response than NFZ. Kinetic of the ratio of fluorescence over
OD600 is shown for dinB
+, DdinB,a n dDrecA strains carrying psulAp-
GFP. Strains were treated with MMS (7.5 mM), NFZ (0.06 mM
shown), or Cip (0.1 mg/mL). Fluorescence readings and optical
density (600 nM) were taken every 5 minutes for 20 hours in a plate
reader. Data shown are the average of at least 4 replicates, and the
standard deviation of the mean is #25% for all samples.
(TIF)
Table S1 Strain, Plasmid, and Oligonucleotide Table.
(TIF)
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